News
OPHLF
12.22
NaN%
--
Ono Pharmaceutical reports Q2 results
Seeking Alpha · 10/30 12:52
ONO Pharmaceutical Reports Strong Q2 Financial Performance with Revenue Growth
TipRanks · 10/30 03:22
Ono Pharmaceutical’s Tirabrutinib Study: Key Insights for Investors
TipRanks · 10/27 23:02
Ono Pharmaceutical’s Phase 3 Trial: A New Hope for PCNSL Treatment
TipRanks · 10/27 21:42
Ono Pharmaceutical’s ONO-1110: A Promising Study for Interstitial Cystitis
TipRanks · 10/27 21:14
ONO Pharmaceutical Advances Fibromyalgia Treatment with ONO-1110 Study
TipRanks · 10/27 21:10
Ono Pharmaceutical’s ONO-4538 Study: A Potential Game-Changer for Richter’s Transformation
TipRanks · 10/27 20:58
Bristol-Myers Squibb and ONO Pharmaceutical’s New Study on Nivolumab for NSCLC: What Investors Need to Know
TipRanks · 10/27 20:43
ONO Pharmaceutical’s BRILLIANT Study: A Potential Breakthrough for Steroid-resistant Pemphigus
TipRanks · 10/27 19:08
Ono Pharmaceutical’s ONO-1110: A Promising Treatment for Postherpetic Neuralgia
TipRanks · 10/27 18:52
ONO Pharmaceutical’s Phase III Study on Cenobamate: A Potential Game-Changer for Epilepsy Treatment
TipRanks · 10/27 18:35
Ono Pharmaceutical’s ONO-4538 Study: A Closer Look at Its Market Potential
TipRanks · 10/27 18:22
ONO Pharmaceutical’s ONO-2020: A Promising Study in Alzheimer’s Agitation
TipRanks · 10/27 18:22
Ono Pharmaceutical’s Cenobamate Study: A Potential Game-Changer for Epilepsy Treatment
TipRanks · 10/27 18:22
ONO Pharmaceutical’s ONO-1110 Trial: A Potential Game-Changer for Major Depressive Disorder
TipRanks · 10/27 18:22
Ono Pharmaceutical’s ONO-4538: A Promising Study in Rhabdoid Tumor Treatment
TipRanks · 10/27 18:22
ONO Pharmaceutical’s ONO-4685: A Promising Phase I Study in T Cell Lymphoma and CLL/SLL
TipRanks · 10/27 18:22
Ono Pharmaceutical’s ONO-1110: A Promising Study for Social Anxiety Disorder
TipRanks · 10/27 18:21
ONO Pharmaceutical’s ONO-7428 Study: A New Hope for Solid Tumor Treatment
TipRanks · 10/27 18:21
Ono Pharmaceutical’s ONO-4685 Study: A Potential Game Changer in T Cell Lymphoma Treatment
TipRanks · 10/27 18:21
More
Webull provides a variety of real-time OPHLF stock news. You can receive the latest news about Ono Pharmaceutic through multiple platforms. This information may help you make smarter investment decisions.
About OPHLF
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.